Titan Pharmaceuticals Inc. (NASDAQ: TTNP) Stock Information | RedChip

Titan Pharmaceuticals Inc. (NASDAQ: TTNP) Listen to this Section


$5.50
N/A ( 0% ) 15.1K

Titan Pharmaceuticals Inc is a development stage company developing proprietary therapeutics with utilizing ProNeura long-term, continuous drug delivery technology. The ProNeura technology has the potential to be used in developing products for treating a number of chronic conditions, where maintaining consistent, around-the-clock blood levels of medication may benefit the patient and improve medical outcomes.

Market Data


Open


$5.50

Previous close


$5.50

Volume


15.1K

Market cap


$4.59M

Day range


$5.08 - $5.70

52 week range


$4.24 - $11.40

Insider Ownership Transactions

Total Amount Purchased: -135,382.00 | $ -744,601.00

Date Type Amount Purchased Purchaser
2024-03-27 Sale -54132.00 Choong Choon Hau
2023-10-26 Sale -16250.00 Ben-Tzvi Avraham
2023-10-26 Sale -16250.00 Beebe Katherine
2023-10-26 Sale -16250.00 Greenberg Eric Howard
2023-10-26 Sale -16250.00 McMurdo Matthew Charles
2023-10-26 Sale -16250.00 NATAN DAVID

SEC Fillings


Form Type Description Pages Date
10-q Quarterly Reports 44 Aug 15, 2024
nt Quarterly Reports 1 Aug 15, 2024
10-q Quarterly Reports 46 May 15, 2024
3 Insider transactions 1 Apr 05, 2024
3 Insider transactions 1 Apr 05, 2024
8-k 8K-related 17 Apr 03, 2024
8-k 8K-related 13 Apr 01, 2024
10-k Annual reports 74 Apr 01, 2024
4 Insider transactions 1 Mar 27, 2024
8-k 8K-related 13 Mar 21, 2024

Latest News


Terms and Agreement

Please agree to the terms to continue using the chat feature.